• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • APIGENIN
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CIANIDANOL
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CYANIDIN
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • ELLAGIC ACID
      • EMBELIN
      • ERIODICTYOL
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MENAQUINONE 4
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PHLORIZIN
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ADAPTOGENS
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • ADDICTION & THE BRAIN
      • ADDICTION & STRESS
      • ADDICTION WITHDRAWAL
      • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
      • ADIPOCYTE DIFFERENTIATION
      • ADROPIN
      • ALLERGIES & CYTOKINES
      • ALDOSTERONE & OBESITY/HYPERTENSION
      • ALZHEIMER’S, DEMENTIA, PARKINSON’S
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADDICTION TREATMENT
      • ADDICTION & DOPAMINE
      • AMPK
      • ANTI AGING
      • ANTIAGING EFFECTS OF COFFEE
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI ATHEROGENIC
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI CARIOGENIC (Protecting From Tooth Decay)
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI GLYCATIVE
      • ANTI GLYCATION AGENTS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • ANXIOLYTIC
      • APOPTOSIS
      • APOPTOSIS IN 3T3-L1
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BDNF
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BIOMIMETIC HYDROXYAPATITE
      • BMI-1
      • BPA & OBESITY
      • BRASSINOSTEROIDS
      • CALORIE RESTRICTION
      • CALORIE RESTRICTION & LIFESPAN EXTENSION
      • CARBAMYLATION
      • CARBONYL SCAVENGER
      • CARBONYL STRESS
      • CARDIOPROTECTIVE AGENTS
      • CARDIAC GLYCOSIDES
      • CATALASE
      • CELL CYCLE ARREST
      • CENTENARIANS
      • CDK5
      • CHOLESTEROL EFFLUX
      • COGNITIVE ENHANCEMENT
      • COLD SHOCK PROTEINS
      • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
      • CONDITIONED PLACE PREFERENCE
      • CORTICOTROPIN RELEASING FACTOR
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DEPERSONALIZATION
      • DIABETES & CANCER
      • DIHYDROTESTOSTERONE (DHT)
      • DNA METHYLATION & AGING
      • DNA REPAIR
      • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
      • DRY FASTING AND FLUID RESTRICTION FASTING
      • DYNORPHIN
      • ELLAGITANNINS
      • ENDOCRINE DISRUPTING CHEMICALS
      • ENLARGED HEART AND CARDIOMEGALY
      • EPIGENETIC MODIFIERS
      • EPINEPHRINE
      • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
      • EXCITOXICITY & THE BRAIN
      • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
      • EXTENDS LIFESPAN
      • EXTINCTION TRAINING
      • FASTING & THE BRAIN
      • FASTING & CANCER
      • FASTING MIMICKING DIET
      • FEAR EXTINCTION
      • FGF21
      • FLAVONES
      • GABA (γ-AMINOBUTYRIC ACID)
      • GALLOTANNINS
      • GLUCONEOGENESIS
      • GLUCOCORTICOID RECEPTOR ACTIVATION
      • GLUTAMATE & BRAIN
      • GLYCATION
      • GUT BRAIN AXIS
      • KLOTHO
      • K OPIOD RECEPTOR & ADDICTION
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HALLMARKS OF AGING
      • HAIR REPIGMENTATION
      • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
      • HMGB1
      • HORMESIS
      • HPA AXIS
      • HSP70, THE ANTI-AGING PROTEIN
      • HSP90 INHIBITORS
      • HYPERGLYCEMIA
      • HYPERALGESIA
      • HYPERINSULINEMIA
      • HYPOTHALAMIC PITUITARY ADRENAL HPA AXIS
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • HYPOCRETIN OREXIN
      • IKK
      • IL-6/STAT3
      • IRISIN
      • ISOFLAVONES
      • IMMUNOSENESCENCE
      • INCREASE PROTEIN SYNTHESIS
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INHIBITION OF RENAL GLUCOSE REABSORPTION
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INSULIN OXIDATIVE STRESS
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LEYDIG CELL STEROIDOGENESIS
      • LIFESPAN EXTENSION
      • LIPOLYTIC AGENTS
      • LIPID DROPLETS
      • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MEDITERRANEAN DIET
      • METABOLIC REPROGRAMMING
      • METABOLIC SYNDROME
      • METHIONINE RESTRICTION
      • MITOCHONDRIAL UNCOUPLING
      • MONKEYPOX
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MUSCLE FORCE PRODUCTION
      • MUSCLE ATROPHY (PREVENTING)
      • MYOGENESIS
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTORC2
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL ANTICOAGULANTS
      • NATURAL AROMATASE INHIBITORS
      • NEUROGENESIS (GROWING NEW BRAIN CELLS)
      • NEUROCHEMISTRY OF ADDICTION
      • NEUROPLASTICITY
      • NEUROINFLAMMATION
      • NEUROPROTECTIVE AGENTS
      • NEUTRALIZING OXIDATIVE STRESS WITH MEDICINAL PLANTS
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR & FEAR
      • NON OPIOD ANALGESICS
      • NOOTROPICS
      • NORADRENERGIC
      • NOREPINEPHRINE
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • OBESOGENS
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OVERNUTRITION
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PERIODONTITIS
      • PHYTOCHEMICALS
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • PROANTHOCYANIDINS
      • PROTEIN CARBONYLATION
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • POLYPHENOLS AS COVID-19 TREATMENT & PREVENTION
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • PUFAS
      • PURGATIVES
      • RAPAMYCIN (MTOR INHIBITION)
      • RED WINE
      • RENAL (KIDNEY) PROTECTIVE AGENTS
      • REMINERALIZATION OF TEETH
      • REPAIR OF DNA BREAKS “DOUBLE STRAND”
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SEX HORMONE BINDING GLOBULIN
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SGLT2 INHIBITORS
      • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
      • SHBG
      • SIRT1
      • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
      • SIRT1 & LONGEVITY
      • SMALLPOX
      • SUGAR & AGING
      • STAR PROTEIN
      • STAT3
      • STEM CELL EXHAUSTION
      • STEM CELL REGENERATION
      • STEM CELL THERAPY
      • STIMULATED LIPOLYSYS
      • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
      • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
      • STRESS & AGING
      • STRESS & THE BRAIN
      • TELOMERE SHORTENING & PREMATURE AGING
      • TIME RESTRICTED FEEDING
      • THROMBOLYTICS (PLANT BASED)
      • TRAUMATIC BRAIN INJURY (HEALING)
      • TRYPTOPHAN HYDROXYLASE 2
      • VISCERAL ADIPOSITY
      • XENOBIOTICS
      • XENOESTROGEN
    • HOME
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    CRYOTHERAPY
    February 19, 2021
    OXYTOCIN
    February 19, 2021
    1. … hormonal treatment for vulvovaginal atrophy in women with estrogen receptor-positive breast cancer who are on adjuvant Aromatase inhibitor therapy: meta-analysis
    2. 11 Aromatase inhibitors
    3. 2 Recent Developments in Aromatase Inhibition as a Potential Treatment for Oestrogen-Dependent Breast Cancer
    4. 227 EFFECTS OF A SINGLE DOSE OF A NONSTEROIDAL Aromatase INHIBITOR ON OVARIAN FUNCTION IN CATTLE
    5. 4 EFFECT OF A PROLONGED Aromatase INHIBITOR TREATMENT ON PRE-OVULATORY OVARIAN FOLLICLES IN CATTLE
    6. A new class of nonsteroidal Aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes Aromatase and 17α …
    7. A novel activity for a group of sesquiterpene lactones: inhibition of Aromatase
    8. A pilot study comparing the effect of flaxseed, Aromatase inhibitor, and the combination on breast tumor biomarkers
    9. Activating mutations of ESR1, BRCA1 and CYP19 Aromatase genes confer tumor response in breast cancers treated with antiestrogens
    10. Advances in the stereoselective synthesis of antifungal agents and Aromatase inhibitors
    11. Anti-Aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus)
    12. Anti-Aromatase activity of the constituents from damiana (Turnera diffusa)
    13. Anti‐Aromatase Chemicals in Red Wine
    14. Aromatase activity in quail brain: correlation with aggressiveness
    15. Aromatase activity in the ovary and brain of the eastern mosquitofish (Gambusia holbrooki) exposed to paper mill effluent.
    16. Aromatase and 17β-hydroxysteroid dehydrogenase inhibition by flavonoids
    17. Aromatase inhibition by an 11, 13-dihydroderivative of a sesquiterpene lactone
    18. Aromatase inhibition by flavonoids
    19. Aromatase inhibition by synthetic lactones and flavonoids in human placental microsomes and breast fibroblasts—a comparative study
    20. Aromatase inhibition: determinants of response and resistance
    21. Aromatase inhibitor of formestane and letrozole on sexual differentiation of muscovy [J]
    22. Aromatase Inhibitor, Flax seed and Sage Effects on Adult Rats Fertility and Sexual Behavior
    23. Aromatase inhibitors and their potential clinical significance
    24. Aromatase inhibitors in Breast Cancer: The Discovery of New Compounds by Computational Design and Biochemical Evaluation
    25. Aromatase inhibitors in breast cancer: the discovery of new computational design and biochemical evaluation
    26. Aromatase inhibitors in cigarette smoke, tobacco leaves and other plants
    27. Aromatase inhibitors in the treatment of breast cancer
    28. Aromatase inhibitors: a new paradigm in breast cancer treatment
    29. Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer
    30. Aromatase inhibitors: past, present and future
    31. Aromatase inhibitors: rationale and use in breast cancer
    32. Aromatase inhibitors: structural features and biochemical characterization
    33. Aromatase inhibitory activity of geranylated coumarins, mammeasins C and D, isolated from the flowers of Mammea siamensis
    34. Aromatase inhibitory, radical scavenging, and antioxidant activities of depsidones and diaryl ethers from the endophytic fungus Corynespora cassiicola L36
    35. Aromatase modulation alters gonadal differentiation in developing zebrafish (Danio rerio)
    36. Aromatase, 3β-HYDROXYSTEROID DEHYDROGENASE Δ5/Δ4 ISOMERASE AND 17β-HYDROXYSTEROID DEHYDROGENASE INHIBITION BY …
    37. Aromatase, Aromatase inhibitors, and breast cancer
    38. Aromatase: contributions to physiology and disease in women and men
    39. Assessing effects of Aromatase inhibition on fishes with group-synchronous oocyte development using western mosquitofish (Gambusia affinis) as a model
    40. Assessment of chemical effects on Aromatase activity using the H295R cell line
    41. Assessment of the Aromatase Inhibitory Activity of Ma-Huang-Tang (MHT) and Its Active Compounds
    42. Bis (4-hydroxy-2H-chromen-2-one) coumarin induces apoptosis in MCF-7 human breast cancer cells through Aromatase inhibition
    43. Brain Aromatase: roles in reproduction and neuroprotection
    44. Cactus flower extracts may prove beneficial in benign prostatic hyperplasia due to inhibition of 5α reductase activity, Aromatase activity and lipid peroxidation
    45. Cannabinoid as Potential Aromatase Inhibitor Through Molecular Modeling and Screening for Anti-Cancer Activity
    46. Chalcones are potent inhibitors of Aromatase and 17β-hydroxysteroid dehydrogenase activities
    47. Changes of breast cancer growth and metastasis in murine models modulated by an Aromatase inhibitor, a low calcium diet or a high fat diet
    48. Characterization of Aromatase binding agents from the dichloromethane extract of Corydalis yanhusuo using ultrafiltration and liquid chromatography tandem mass …
    49. Chemical Constituents from Artemisia annua and Vitex agnus-castus as New Aromatase inhibitors: In-vitro and In-silico Studies
    50. Chemoendocrine metronomic therapy of estrogen receptor-positive breast cancer by taxanes or capecitabine in combination with Aromatase inhibitors
    51. Chrysin: is it an effective Aromatase inhibitor
    52. Clinical and Genetic Predictors of Aromatase Inhibitor-Induced Arthralgia
    53. Coadministrating luteolin minimizes the side effects of the Aromatase inhibitor letrozole
    54. Coadministration of the Aromatase inhibitor formestane and an isopropanolic extract of black cohosh in a rat model of chemically induced mammary carcinoma
    55. Comparison of the effects of nobiletin and letrozole on the activity and expression of Aromatase in the MCF-7 breast cancer cell line
    56. Comprehensive and automated linear interaction energy based binding-affinity prediction for multifarious cytochrome P450 Aromatase inhibitors
    57. Computational investigations of cytochrome P450 Aromatase catalysis and biological evaluation of isoflavone Aromatase inhibitors
    58. Computational methods for the design of potent Aromatase inhibitors
    59. Correlation of rs749292 and rs700518 polymorphisms in the Aromatase gene (CYP19A1) with osteoporosis in postmenopausal Polish women
    60. Currently used pesticides and their mixtures affect the function of sex hormone receptors and Aromatase enzyme activity
    61. De novo designing, assessment of target affinity and binding interactions against Aromatase: Discovery of novel leads as anti-breast cancer agents
    62. Depsidones inhibit Aromatase activity and tumor cell proliferation in a co-culture of human primary breast adipose fibroblasts and T47D breast tumor cells
    63. Design, synthesis and activity of flavonoids Aromatase inhibitors
    64. Design, synthesis, and 3D QSAR of novel potent and selective Aromatase inhibitors
    65. Development of an LC-MS/MS method for Aromatase inhibitor screening
    66. Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF‐7 cells overexpressing Aromatase
    67. Disruption of Aromatase homeostasis as the cause of a multiplicity of ailments: A comprehensive review
    68. Distribution of Aromatase activity in brain and peripheral tissues of male sheep: effect of nutrition
    69. Diverse functions of Aromatase: O-deethylation of 7-ethoxycoumarin
    70. DNA methylation of the gonadal Aromatase (cyp19a) promoter is involved in temperature-dependent sex ratio shifts in the European sea bass
    71. Drugs used for ovarian stimulation: Clomiphene citrate, Aromatase inhibitors, metformin, gonadotropins, gonadotropin-releasing hormone analogs, and recombinant …
    72. Effect of Aromatase inhibitors on the ovarian development of stunted yearlings of rohu (Labeo rohita): a preliminary study
    73. Effect of Buthus martensi Karsch on Aromatase Activity and Cytokine-Inducded NOS and NO Production in Osteoblasts and Leukaemic Cell Line FLG 29.1
    74. Effect of Genistein and 2, 3, 7, 8-tetrachlorodibenzo_; 7a/^ a-TCDD On Aromatase Activity
    75. Effect of Hop (Humulus lupulus L.) Flavonoids on Aromatase (Estrogen Synthase) Activity
    76. Effect of the application of Aromatase inhibitors on sex reversal and zootechnical performance of broiler chicken.
    77. Effective anti-Aromatase therapy to battle against estrogen-mediated breast cancer: Comparative SAR/QSAR assessment on steroidal Aromatase inhibitors
    78. Effects of a non-steroidal Aromatase inhibitor on ovarian function in cattle
    79. Effects of atrazine on CYP19 gene expression and Aromatase activity in testes and on plasma sex steroid concentrations of male African clawed frogs (Xenopus laevis …
    80. Effects of atrazine on metamorphosis, growth, laryngeal and gonadal development, Aromatase activity, and sex steroid concentrations in Xenopus laevis
    81. Effects of currently used pesticides in assays for estrogenicity, androgenicity, and Aromatase activity in vitro
    82. Effects of exposure to oestrogenic compounds on Aromatase gene expression are gender dependent in the rainbowfish, Melanotaenia fluviatilis
    83. Effects of Isoflavones on Estrogen Receptor Mediated Estrogenicity and Aromatase Activity
    84. Effects of lactone derivatives on Aromatase (CYP19) activity in H295R human adrenocortical and (anti) androgenicity in transfected LNCaP human prostate cancer …
    85. Effects of maternal exposure to an Aromatase inhibitor on sexual behaviour and neurochemical and endocrine aspects of adult male rat
    86. Effects of neonicotinoids on promoter-specific expression and activity of Aromatase (CYP19) in human adrenocortical carcinoma (H295R) and primary umbilical vein …
    87. Effects of nutrition relevant mixtures of phytoestrogens on steroidogenesis, Aromatase, estrogen, and androgen activity
    88. Effects of Ovarian Development by P450 Aromatase Activity Controled in Mice [J]
    89. Effects of phytoestrogens on Aromatase, 3β and 17β-hydroxysteroid dehydrogenase activities and human breast cancer cells
    90. Effects of the Aromatase inhibitor fadrozole on gene expression in the zebrafish brain
    91. Efficacy of cactus flowers miller treatment in benign prostatic hyperplasia due to inhibition of 5α reductase activity, Aromatase activity and lipid peroxidation.
    92. Efficacy of management strategies for Aromatase inhibitor‐induced arthralgia in breast cancer patients: a systematic review
    93. Egonol gentiobioside and egonol gentiotrioside from Styrax perkinsiae promote the biosynthesis of estrogen by Aromatase
    94. Emerging Chemicals Targeting Aromatase: Protective Compounds or Endocrine Disruptors?
    95. Enhanced Expression of Aromatase in Tamoxifen Resistant Human Breast Cancer
    96. Enzymatic control of estrogen production in human breast cancer: relative significance of Aromatase versus sulfatase pathways
    97. Ergostane-type sterols from king trumpet mushroom (Pleurotus eryngii) and their inhibitory effects on Aromatase
    98. Eurycomanone, the major quassinoid in Eurycoma longifolia root extract increases spermatogenesis by inhibiting the activity of phosphodiesterase and Aromatase in …
    99. Evaluation of a 40 day assay for testing endocrine disrupters: effects of an anti-estrogen and an Aromatase inhibitor on sex ratio and vitellogenin concentrations in …
    100. Evaluation of Synthesized Ester or Amide Coumarin Derivatives on Aromatase Inhibitory Activity
    101. Evaluation of the Aromatase Inhibitor Fadrozole in a Short-Term Reproduction Assay with the Fathead Minnow (Pimephales promelas)
    102. Evaluation of the biochemical activity of new modified steroids as Aromatase inhibitors
    103. Evaluation of the biochemical activity of new modified steroids as Aromatase inhibitors
    104. Evaluation of ursolic acid isolated from Ilex paraguariensis and derivatives on Aromatase inhibition
    105. Everolimus downregulates estrogen receptor and induces autophagy in Aromatase inhibitor-resistant breast cancer cells
    106. Extraction, isolation, and Aromatase inhibitory evaluation of low-polar ginsenosides from Panax ginseng leaves
    107. Fadrozole hydrochloride: a potent, selective, nonsteroidal inhibitor of Aromatase for the treatment of estrogen-dependent disease
    108. Fetal safety profile of Aromatase inhibitors: Animal data
    109. Flavans from Desmos cochinchinensis as potent Aromatase inhibitors
    110. Flavonoid inhibition of Aromatase enzyme activity in human preadipocytes
    111. GBEs as an Aromatase Inhibitor for Hormone Adjuvant Therapy
    112. Genistein induces breast cancer-associated Aromatase and stimulates estrogen-dependent tumor cell growth in in vitro breast cancer model
    113. Growth inhibitory efficacy and anti‑Aromatase activity of Tabebuia avellanedae in a model for post‑menopausal Luminal A breast cancer
    114. Hexanol Extracts of Cyperus Rotundus Inhibited Aromatase Activity in JEG-3 Cells
    115. HUMAN Aromatase GENE EXPRESSION IN ADIPOSE TISSUE
    116. Hypothalamic–pituitary–gonadal axis in two men with Aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the …
    117. Icariin from Epimedium brevicornum Maxim promotes the biosynthesis of estrogen by Aromatase (CYP19)
    118. Identification of endocrine disrupting chemicals acting on human Aromatase
    119. Impairment of spermatogenesis in mice lacking a functional Aromatase (cyp 19) gene
    120. In silico Docking Approach of Coumarin Derivatives as an Aromatase Antagonist
    121. Incidence of menopausal symptoms in postmenopausal breast cancer patients treated with Aromatase inhibitors
    122. Increased sperm cell production in ageing roosters by an oral treatment with an Aromatase inhibitor and a natural herbal extract designed for improving fertility
    123. Induction and inhibition of Aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells
    124. Inhibition of Aromatase and cell proliferation of breast cancer and human placenta choriocarcinoma by Prunus persica extracts
    125. Inhibition of Aromatase and α-Amylase by Flavonoids and Proanthocyanidins from Sorghum bicolor Bran Extracts
    126. Inhibitory Aromatase effects of flavonoids from Ginkgo biloba extracts on estrogen biosynthesis
    127. Inhibitory effect of chrysin on estrogen biosynthesis by suppression of enzyme Aromatase (CYP19): A systematic review
    128. Inhibitory effect of luteolin on estrogen biosynthesis in human ovarian granulosa cells by suppression of Aromatase (CYP19)
    129. Inhibitory effect of Sphagnum palustre extract and its bioactive compounds on Aromatase activity
    130. Inhibitory effects of Ginkgo biloba extract on Aromatase activity and tumor suppression in Aromatase xenograft model
    131. Integrated in silico-in vitro strategy for screening of some traditional Egyptian plants for human Aromatase inhibitors
    132. Interference of endocrine disrupting chemicals with Aromatase CYP19 expression or activity, and consequences for reproduction of teleost fish
    133. Interrelationships between Aromatase and cyclooxygenase-2 and their role in the autocrine and paracrine mechanisms in breast cancer
    134. Investigating the Effects of Aromatase inhibitors on the Musculoskeletal System
    135. Lead molecules as novel Aromatase inhibitors: in silico de novo designing and binding affinity studies
    136. Levels of Aromatase and Estrogen Receptors mRNA in Early Larvae of Alburnus tarichi (Güldenstӓdt, 1814) Exposed to Di-(2-ethylhexyl)-phthalate
    137. Luteolin-7-methylether from Leonurus japonicus inhibits estrogen biosynthesis in human ovarian granulosa cells by suppression of Aromatase (CYP19)
    138. Mammalian lignans and genistein decrease the activities of Aromatase and 17β-hydroxysteroid dehydrogenase in MCF-7 cells
    139. Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant Aromatase inhibitor therapy
    140. Mechanism and inhibition of cytochrome P-450 Aromatase
    141. Modulation of Aromatase activity as a mode of action for endocrine disrupting chemicals in a marine fish
    142. Modulation of Aromatase by natural compounds—A pharmacophore guided molecular modelling simulations
    143. Modulation of Aromatase by phytoestrogens
    144. Molecular basis for the interaction of four different classes of substrates and inhibitors with human Aromatase
    145. Molecular cloning and developmental expression of Aromatases gene in two species of loaches
    146. Molecular docking studies on borapetol with target Aromatase related to breast cancer
    147. Molecular Modelling of Estrogen-Producing Enzymes CYP450 Aromatase and 17beta-Hydroxysteroid Dehydrogenase Type 1
    148. Molecular pharmacology of Aromatase and its regulation by endogenous and exogenous agents
    149. Musculoskeletal side effects of Aromatase inhibitors treatment in women with breast cancer
    150. natural product compounds with Aromatase inhibitory activity: an update
    151. natural products as Aromatase inhibitors: Identification and structure-activity aspects
    152. Nelumal A, the Active Principle of Ligularia nelumbifolia, is a Novel Aromatase Inhibitor
    153. New 7, 8-benzoflavanones as potent Aromatase inhibitors: synthesis and biological evaluation
    154. No evidence for the in vivo activity of Aromatase-inhibiting flavonoids
    155. No indications of socially induced changes in brain Aromatase activity in guppy (Poecilia reticulata) males
    156. Nonsteroidal Aromatase inhibitors for the treatment of breast cancer: an update
    157. Nonsteroidal Aromatase inhibitors: recent advances
    158. Novel inhibitor discovery against Aromatase through virtual screening and molecular dynamic simulation: a computational approach in drug design
    159. Novel irreversible Aromatase inhibitors
    160. Nutrigenomics-associated impacts of nutrients on genes and enzymes with special consideration of Aromatase
    161. Optimization of the Aromatase inhibitory activities of pyridylthiazole analogues of resveratrol
    162. Origin of Aromatase inhibitory activity via proteochemometric modeling
    163. P450 Aromatase alterations and DNA damage as avian pollution biomarkers in cliff and cave swallow breeding near the Rio Grande region, Texas
    164. Pattern of Aromatase mRNA expression in the brain of a weakly electric fish, Apteronotus leptorhynchus
    165. Pharmacophore mapping of flavone derivatives for Aromatase inhibition
    166. Phytochemicals for breast cancer prevention by targeting Aromatase
    167. Phytoestrogens inhibit Aromatase but not 17β‐hydroxysteroid dehydrogenase (HSD) type 1 in human granulosa‐luteal cells: evidence for FSH induction of 17β‐HSD
    168. PLACENTAL Aromatase ASSAY VALIDATION STUDY: POSITIVE CONTROL STUDY
    169. Potential effect of Olea europea leaves, Sonchus oleraceus leaves and Mangifera indica peel extracts on Aromatase activity in human placental microsomes and …
    170. Potential effects of environmental contaminants on P450 Aromatase activity and DNA damage in swallows from the Rio Grande and Somerville, Texas
    171. Potential utility of natural products as regulators of breast cancer-associated Aromatase promoters
    172. PRE-VALIDATION STUDY PLAN AND STUDY PROTOCOL FOR THE Aromatase ASSAY USING HUMAN, BOVINE, AND PORCINE PLACENTA, AND …
    173. Probing the origins of Aromatase inhibitory activity of disubstituted coumarins via QSAR and molecular docking
    174. Probing the xeno-oestrogenic impact of sediment cores contaminated by the pulp and paper industry: induction of Aromatase cyp19a1b in late larval zebrafish
    175. Prostaglandin E2-9-Ketoreductase and Prostaglandin F2α Activate Brain Aromatase to Induce Courtship in the Male Crested Newt, Triturus carnifex
    176. QSAR modeling of Aromatase inhibitory activity of 1-substituted 1, 2, 3-triazole analogs of letrozole
    177. QSAR study of diarylalkylimidazole and diarylalkyltriazole Aromatase inhibitors
    178. Quillaja saponins inhibit tilapia Aromatase activity in vitro
    179. Randomized, double-blind, placebo-controlled phase ii clinical trial on the use of uncaria tomentosa (Cat’s claw) for Aromatase inhibitor-induced arthralgia: A pilot …
    180. Recent advancement in nonsteroidal Aromatase inhibitors for treatment of estrogen-dependent breast cancer
    181. Recent Studies on Aromatase and Sulfatase Involved in Breast Cancer and their inhibitors
    182. Refinement of an OECD test guideline for evaluating the effects of endocrine disrupting chemicals on Aromatase gene expression and reproduction using novel …
    183. Regulation of Aromatase expression in breast cancer tissue
    184. Role of EGB 761 as a Possible Aromatase Inhibitor for Breast Cancer Therapy
    185. Role of estrogen receptors and Aromatase on brain protein synthesis rates in ovariectomized female rats fed genistein
    186. Screening for Aromatase ligands in the extract of Broussonetia papyrifera using high performance liquid chromatography and ESI-mass spectrometry
    187. Screening of herbal constituents for Aromatase inhibitory activity
    188. Selection of Appropriate Inhibitor for Ovarian Type Cytochrome P450 Aromatase Gene of Heteropneustesfossilis with the Application of Homology Modeling …
    189. Selective Inhibition of Aromatase by a Dihydroisocoumarin from Xyris pterygoblephara
    190. Sensitivity of New Zealand mudsnail Potamopyrgus antipodarum (Gray) to a specific Aromatase inhibitor
    191. Sex reversal of the amphibian, Xenopus tropicalis, following larval exposure to an Aromatase inhibitor
    192. Steroid and growth factor modulation of Aromatase activity in MCF7 and T47D breast carcinoma cell lines
    193. Steroidal alkaloids efficient Aromatase inhibitors with potential for the treatment of postmenopausal breast cancer
    194. Structure–function studies of Aromatase and its inhibitors: a progress report
    195. Superiority of Aromatase inhibitor and cyclooxygenase-2 inhibitor combined delivery: hyaluronate-targeted versus PEGylated protamine nanocapsules for breast …
    196. Suppression of Aromatase (estrogen synthetase) by red wine phytochemicals
    197. Suppression of Aromatase activity in populations of bream (Abramis brama) from the river Elbe, Germany
    198. Synthesis and Aromatase inhibition properties of new boronic acid chalcone derivatives
    199. Synthesis and Aromatase inhibitory activity of novel pyridine-containing isoflavones
    200. Synthesis and biological evaluation of (±)-abyssinone II and its analogues as Aromatase inhibitors for chemoprevention of breast cancer
    201. Synthesis of Aromatase inhibitors and quinone reductase inducers for cancer chemoprevention studies
    202. Synthesis of casimiroin and optimization of its quinone reductase 2 and Aromatase inhibitory activities
    203. Synthesis of dl-standishinal and its related compounds for the studies on structure–activity relationship of inhibitory activity against Aromatase
    204. Synthesis of enterolactone and enterodiol precursors as potential inhibitors of human estrogen synthetase (Aromatase)
    205. Synthetic isoflavones and doping: A novel class of Aromatase inhibitors?
    206. Tebuconazole Disrupted Aromatase Activity and Reduced 17β-Estradiol Concentration in Pubertal Developmental Rats
    207. Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by Aromatase in endothelial cells: implications in atherosclerosis
    208. Thalassosterol, a new cytotoxic Aromatase inhibitor ergosterol derivative from the Red Sea seagrass Thalassodendron ciliatum
    209. The citrus flavonone hesperetin inhibits growth of Aromatase-expressing MCF-7 tumor in ovariectomized athymic mice
    210. The combined effects of temperature and Aromatase inhibitor on metamorphosis, growth, locomotion, and sex ratio of tiger frog (Hoplobatrachus rugulosus) …
    211. The Effect of in ovo Injection of Aromatase inhibitors on the Performance of Broilers
    212. The effects of Nobiletin, Hesperetin, and Letrozole in a combination on the activity and expression of Aromatase in breast cancer cells
    213. The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of Aromatase gene expression
    214. The phenotype of the Aromatase knockout mouse reveals dietary phytoestrogens impact significantly on testis function
    215. The plant polyphenol butein inhibits testosterone-induced proliferation in breast cancer cells expressing Aromatase
    216. The red wine polyphenol resveratrol displays bilevel inhibition on Aromatase in breast cancer cells
    217. The roles of sex steroids and their receptors in the regulation of brain Aromatase expression
    218. The use of Aromatase inhibitors in boys with short stature: what to know before prescribing?
    219. The use of the Klopman index as a new descriptor for pharmacophore analysis on strong Aromatase inhibitor flavonoids against estrogen-dependent breast cancer
    220. Total syntheses of the Aromatase inhibitors, mammeasins C and D, from Thai medicinal plant Mammea siamensis
    221. Total synthesis of the Aromatase inhibitor dihydroisocoumarin via protective opening of lactones
    222. Towards understanding Aromatase inhibitory activity via QSAR modeling
    223. White button mushroom phytochemicals inhibit Aromatase activity and breast cancer cell proliferation
    224. α-Glucosidase inhibitory, Aromatase inhibitory, and antiplasmodial activities of a biflavonoid GB1 from Garcinia kola stem bark
    Share
    0
    INTERSTELLAR BLEND

    Related posts

    August 10, 2022

    THROMBOLYTICS (PLANT BASED)


    Read more
    August 10, 2022

    XENOESTROGEN


    Read more
    August 10, 2022

    GLUCOCORTICOID RECEPTOR ACTIVATION


    Read more

    Comments are closed.

    Recent Posts

    • THROMBOLYTICS (PLANT BASED)
    • XENOESTROGEN
    • GLUCOCORTICOID RECEPTOR ACTIVATION
    • OBESOGENS
    • XENOBIOTICS
    © 2022 Interstellar Blends | Activate Your Super Powers!. © 2019 Interstellar Blends | Activate Your Super Powers!. All Rights Reserved.

    Mandatory FDA Disclaimer
    Privacy Policy
    Terms and Conditions
    Have Questions?
    Contact Gavin Robert McGowen Here

    Join the following facebook groups to learn more:
    Ultimate Weightloss Challenge , Dry Fasting, Longevity Agents , Interstellar Blend Seven Sages, The Infinitely Postive, THE INTERSTELLAR BLEND CHALLENGE: Fluid Restricted Fasting w/ Superherbs

    Love this Website? Contact David Rodriguez to build you one!